Fundraising Fox
OligoTune
1 known investors
Find your way into OligoTune
Sign up to see every warm intro you have to OligoTune
- Paths you didn't know you had: your email and LinkedIn already hold routes to the OligoTune team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Oligotune is developing RNA-based cancer immunotherapy treatments that target solid tumours with enhanced precision. The company uses a data-driven pre-clinical R&D pipeline to address mechanisms in cancer immunotherapy that existing treatments do not adequately target.
Founders & leadership
Investors · 1
Frequently asked questions
- What does OligoTune do?
- Oligotune is developing RNA-based cancer immunotherapy treatments that target solid tumours with enhanced precision. The company uses a data-driven pre-clinical R&D pipeline to address mechanisms in cancer immunotherapy that existing treatments do not adequately target.
- Who founded OligoTune?
- OligoTune was founded by Loïc, Robert, Loïc Roux, PhD.
- Who are OligoTune's investors?
- OligoTune's investors include Deep Science Ventures.